FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration [Yahoo! Finance]
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit [Yahoo! Finance]
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit